| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute Valproate-Induced Encephalopathy in Status Epilepticus: A Registry-Based Assessment
|
Loser, Valentin
|
|
|
|
8 |
p. 725-731
|
artikel
|
| 2 |
Aβ-Degrading Proteases: Therapeutic Potential in Alzheimer Disease
|
Leissring, Malcolm A.
|
|
2016
|
|
8 |
p. 667-675
|
artikel
|
| 3 |
Alzheimer’s Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials
|
Rafii, Michael S.
|
|
|
|
8 |
p. 785-794
|
artikel
|
| 4 |
Amantadine Extended-Release (GOCOVRI™): A Review in Levodopa-Induced Dyskinesia in Parkinson’s Disease
|
Paik, Julia
|
|
2018
|
|
8 |
p. 797-806
|
artikel
|
| 5 |
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
|
Leisher, Solana
|
|
|
|
8 |
p. 671-677
|
artikel
|
| 6 |
Antiseizure Drugs and Movement Disorders
|
Sáenz-Farret, Michel
|
|
|
|
8 |
p. 859-876
|
artikel
|
| 7 |
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder
|
Nasser, Azmi
|
|
|
|
8 |
p. 897-915
|
artikel
|
| 8 |
A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects
|
Fossler, Michael J.
|
|
|
|
8 |
p. 853-865
|
artikel
|
| 9 |
A Randomized Trial of Iloperidone for Prevention of Relapse in Schizophrenia: The REPRIEVE Study
|
Weiden, Peter J.
|
|
2016
|
|
8 |
p. 735-747
|
artikel
|
| 10 |
Awakenings and Awareness Recovery in Disorders of Consciousness
|
Pistoia, Francesca
|
|
2010
|
|
8 |
p. 625-638
|
artikel
|
| 11 |
Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia
|
Parellada, Eduard
|
|
2016
|
|
8 |
p. 689-701
|
artikel
|
| 12 |
Branched-Chain Amino Acids and Seizures: A Systematic Review of the Literature
|
Gruenbaum, Shaun E.
|
|
2019
|
|
8 |
p. 755-770
|
artikel
|
| 13 |
Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy
|
Hoy, Sheridan M.
|
|
2016
|
|
8 |
p. 761-772
|
artikel
|
| 14 |
Buprenorphine Use in Pregnant Opioid Users: A Critical Review
|
Soyka, Michael
|
|
2013
|
|
8 |
p. 653-662
|
artikel
|
| 15 |
Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System
|
Schonhofen, Patrícia
|
|
2018
|
|
8 |
p. 697-712
|
artikel
|
| 16 |
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
|
Liu, Celina S.
|
|
2015
|
|
8 |
p. 615-623
|
artikel
|
| 17 |
Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study
|
Ludwig, Vera M.
|
|
|
|
8 |
p. 881-892
|
artikel
|
| 18 |
Causes of CNS Inflammation and Potential Targets for Anticonvulsants
|
Falip, Mercé
|
|
2013
|
|
8 |
p. 611-623
|
artikel
|
| 19 |
Cladribine Tablets: A Review in Relapsing MS
|
Deeks, Emma D.
|
|
2018
|
|
8 |
p. 785-796
|
artikel
|
| 20 |
Cladribine Tablets: A Review in Relapsing MS
|
Deeks, Emma D.
|
|
|
|
8 |
p. 785-796
|
artikel
|
| 21 |
Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal ‘Slow Gut’ Reactions, and Comparison with International Drug Safety Advice
|
Every-Palmer, Susanna
|
|
2017
|
|
8 |
p. 699-709
|
artikel
|
| 22 |
Comparative Efficacy and Risk of Harms of Immediate- versus Extended-Release Second-Generation Antidepressants: A Systematic Review with Network Meta-Analysis
|
Nussbaumer, Barbara
|
|
2014
|
|
8 |
p. 699-712
|
artikel
|
| 23 |
Correction to: Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis
|
Sorensen, Per Soelberg
|
|
|
|
8 |
p. 917
|
artikel
|
| 24 |
Correction to: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy
|
Gharaylou, Zeinab
|
|
2019
|
|
8 |
p. 839
|
artikel
|
| 25 |
Correction to: Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study
|
Perlman, Amichai
|
|
|
|
8 |
p. 919
|
artikel
|
| 26 |
Correction to: Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis
|
Lin, Dee
|
|
|
|
8 |
p. 923
|
artikel
|
| 27 |
Correction to: Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life‑Sustaining Therapies: A Systematic Review
|
Willems, Laurent M.
|
|
|
|
8 |
p. 921
|
artikel
|
| 28 |
Correction to: Treatment Strategies for Dravet Syndrome
|
Knupp, Kelly G.
|
|
2018
|
|
8 |
p. 783
|
artikel
|
| 29 |
Cost Effectiveness of Pharmacotherapy for the Prevention of Migraine
|
Yu, Junhua
|
|
2010
|
|
8 |
p. 695-712
|
artikel
|
| 30 |
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications
|
Perucca, Emilio
|
|
|
|
8 |
p. 795-800
|
artikel
|
| 31 |
Diclofenac Potassium Powder for Oral Solution: A Review of Its Use in Patients with Acute Migraine
|
Garnock-Jones, Karly P.
|
|
2014
|
|
8 |
p. 761-768
|
artikel
|
| 32 |
Drug Repurposing in Parkinson’s Disease
|
Athauda, Dilan
|
|
2018
|
|
8 |
p. 747-761
|
artikel
|
| 33 |
Effectiveness and Safety of Switching from Oral Antipsychotics to Once-Monthly Paliperidone Palmitate (PP1M) in the Management of Schizophrenia: A Systematic Review and Meta-Analysis
|
Li, Qian
|
|
|
|
8 |
p. 695-713
|
artikel
|
| 34 |
Effect of Tolcapone on Brain Activity During a Variable Attentional Control Task: A Double-Blind, Placebo-Controlled, Counter-Balanced Trial in Healthy Volunteers
|
Magalona, Sophia C.
|
|
2013
|
|
8 |
p. 663-673
|
artikel
|
| 35 |
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
|
deVries, Tina
|
|
2019
|
|
8 |
p. 783-789
|
artikel
|
| 36 |
Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study
|
Castro, Meredith
|
|
|
|
8 |
p. 715-723
|
artikel
|
| 37 |
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments
|
Faissner, Simon
|
|
|
|
8 |
p. 803-817
|
artikel
|
| 38 |
Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study
|
Weisler, Richard H.
|
|
2017
|
|
8 |
p. 685-697
|
artikel
|
| 39 |
Elucidating the Mechanism of Action of Pregabalin
|
Micó, Juan-Antonio
|
|
|
|
8 |
p. 637-648
|
artikel
|
| 40 |
Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy
|
Childress, Ann C.
|
|
2015
|
|
8 |
p. 683-693
|
artikel
|
| 41 |
Erratum to: Oxycodone/Naloxone PR: A Review in Severe Refractory Restless Legs Syndrome
|
Frampton, James E.
|
|
2015
|
|
8 |
p. 713
|
artikel
|
| 42 |
Erratum to: Plant-Based Medicines for Anxiety Disorders, Part 2: A Review of Clinical Studies with Supporting Preclinical Evidence
|
Sarris, Jerome
|
|
2013
|
|
8 |
p. 675
|
artikel
|
| 43 |
Erratum to: Rediscovering Trazodone for the Treatment of Major Depressive Disorder
|
Fagiolini, Andrea
|
|
2013
|
|
8 |
p. 677
|
artikel
|
| 44 |
Evidence-Based Expert Consensus Regarding Long-Acting Injectable Antipsychotics for Schizophrenia from the Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN)
|
Yang, Kai-Chun
|
|
|
|
8 |
p. 893-905
|
artikel
|
| 45 |
Exploring the Evidence for Broad-Spectrum Effectiveness of Perampanel: A Systematic Review of Clinical Data in Generalised Seizures
|
Trinka, Eugen
|
|
|
|
8 |
p. 821-837
|
artikel
|
| 46 |
GABA-ergic Modulators: New Therapeutic Approaches to Premenstrual Dysphoric Disorder
|
Sikes-Keilp, Christopher
|
|
|
|
8 |
p. 679-693
|
artikel
|
| 47 |
Immune Globulin Subcutaneous (Human) 20% (Hizentra®): A Review in Chronic Inflammatory Demyelinating Polyneuropathy
|
Lamb, Yvette N.
|
|
|
|
8 |
p. 831-838
|
artikel
|
| 48 |
Immune Globulin Subcutaneous (Human) 20% (Hizentra®): A Review in Chronic Inflammatory Demyelinating Polyneuropathy
|
Lamb, Yvette N.
|
|
2019
|
|
8 |
p. 831-838
|
artikel
|
| 49 |
Impact of CNS Stimulants for Attention-Deficit/Hyperactivity Disorder on Growth: Epidemiology and Approaches to Management in Children and Adolescents
|
Baweja, Raman
|
|
|
|
8 |
p. 839-859
|
artikel
|
| 50 |
Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis
|
Overeem, Lucas Hendrik
|
|
|
|
8 |
p. 805-820
|
artikel
|
| 51 |
Intravenous Brivaracetam in the Treatment of Status Epilepticus: A Systematic Review
|
Brigo, Francesco
|
|
2019
|
|
8 |
p. 771-781
|
artikel
|
| 52 |
Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
|
Kumar, Gyanendra
|
|
2015
|
|
8 |
p. 659-667
|
artikel
|
| 53 |
Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis
|
Yang, Yong
|
|
2016
|
|
8 |
p. 677-688
|
artikel
|
| 54 |
Lisdexamfetamine Dimesylate
|
Steer, Christopher
|
|
|
|
8 |
p. 691-705
|
artikel
|
| 55 |
Long-Acting Injectable Formulations of New-Generation Antipsychotics: A Review from a Clinical Perspective
|
Rauch, Anna-Sophia
|
|
2013
|
|
8 |
p. 637-652
|
artikel
|
| 56 |
Low-Dose Doxepin
|
Weber, Juliane
|
|
2010
|
|
8 |
p. 713-720
|
artikel
|
| 57 |
Luteal Phase and Symptom-Onset Dosing of SSRIs/SNRIs in the Treatment of Premenstrual Dysphoria: Clinical Evidence and Rationale
|
Steiner, Meir
|
|
2013
|
|
8 |
p. 583-589
|
artikel
|
| 58 |
Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension
|
Baker, Jacquie
|
|
2017
|
|
8 |
p. 653-663
|
artikel
|
| 59 |
Methadone for Pain Management: A Pharmacotherapeutic Review
|
Kreutzwiser, Denise
|
|
|
|
8 |
p. 827-839
|
artikel
|
| 60 |
Methylene Blue in the Treatment of Neuropsychiatric Disorders
|
Alda, Martin
|
|
2019
|
|
8 |
p. 719-725
|
artikel
|
| 61 |
Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical Aspects
|
Anderson, Gail D.
|
|
2015
|
|
8 |
p. 669-681
|
artikel
|
| 62 |
Naltrexone: A Pan-Addiction Treatment?
|
Aboujaoude, Elias
|
|
2016
|
|
8 |
p. 719-733
|
artikel
|
| 63 |
Nervous System Effects of Antituberculosis Therapy
|
Kass, Joseph S.
|
|
2010
|
|
8 |
p. 655-667
|
artikel
|
| 64 |
Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants
|
Khoo, Ai Leng
|
|
2015
|
|
8 |
p. 695-712
|
artikel
|
| 65 |
Neurological and Psychiatric Adverse Effects of Antimicrobials
|
Bangert, Madison K.
|
|
2019
|
|
8 |
p. 727-753
|
artikel
|
| 66 |
Newer Formulations of Risperidone: Role in the Management of Psychotic Disorders
|
Clark, Ivana
|
|
|
|
8 |
p. 841-852
|
artikel
|
| 67 |
New, Occasional, and Frequent Use of Zolpidem or Zopiclone (Alone and in Combination) and the Risk of Injurious Road Traffic Crashes in Older Adult Drivers: A Population-Based Case–Control and Case-Crossover Study
|
Nevriana, Alicia
|
|
2017
|
|
8 |
p. 711-722
|
artikel
|
| 68 |
Objective Derivation of the Morphology and Staging of Visual Field Loss Associated with Long-Term Vigabatrin Therapy
|
Wild, John M.
|
|
2019
|
|
8 |
p. 817-829
|
artikel
|
| 69 |
Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?
|
Khoo, Shaun Yon-Seng
|
|
2014
|
|
8 |
p. 713-730
|
artikel
|
| 70 |
Osteoporosis and Multiple Sclerosis: Risk Factors, Pathophysiology, and Therapeutic Interventions
|
Gupta, Sahil
|
|
2014
|
|
8 |
p. 731-742
|
artikel
|
| 71 |
Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence
|
Ignatowski, Tracey A.
|
|
2014
|
|
8 |
p. 679-697
|
artikel
|
| 72 |
Pharmacokinetics, Safety, and Tolerability of Intravenous Felbinac Trometamol in Healthy Chinese Volunteers: A First-in-Human Single- and Multiple-Dose Escalation Phase I Study with a Randomized, Double-Blind, Placebo-Controlled Design
|
Wu, Min
|
|
|
|
8 |
p. 867-877
|
artikel
|
| 73 |
Pharmacological Management of Opioid Use Disorder in Pregnant Women
|
Wilder, Christine M.
|
|
2015
|
|
8 |
p. 625-636
|
artikel
|
| 74 |
Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder
|
Naglich, Andrew
|
|
2017
|
|
8 |
p. 665-674
|
artikel
|
| 75 |
Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts
|
Franceschi, Enrico
|
|
2017
|
|
8 |
p. 675-684
|
artikel
|
| 76 |
Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease
|
Perez-Lloret, Santiago
|
|
2016
|
|
8 |
p. 703-717
|
artikel
|
| 77 |
Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists
|
Krystal, John H.
|
|
2010
|
|
8 |
p. 669-693
|
artikel
|
| 78 |
Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study
|
Seery, Nabil
|
|
|
|
8 |
p. 907-918
|
artikel
|
| 79 |
Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia
|
Veselinović, Tanja
|
|
|
|
8 |
p. 819-858
|
artikel
|
| 80 |
Refining the Benefit/Risk Profile of Anti-Epileptic Drugs in Headache Disorders
|
Marmura, Michael J.
|
|
2018
|
|
8 |
p. 735-746
|
artikel
|
| 81 |
Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis
|
Oh, Jiwon
|
|
2013
|
|
8 |
p. 591-609
|
artikel
|
| 82 |
Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension
|
Oertel, Wolfgang H.
|
|
2016
|
|
8 |
p. 749-760
|
artikel
|
| 83 |
Social Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents
|
Frye, Richard E.
|
|
2018
|
|
8 |
p. 713-734
|
artikel
|
| 84 |
Sociodemographic Disparities in Administration of Antiepileptic Drugs to Adults with Epilepsy in Germany: A Retrospective, Database Study of Drug Prescriptions
|
Hamer, Hajo M.
|
|
2014
|
|
8 |
p. 753-759
|
artikel
|
| 85 |
Sodium Oxybate in the Treatment of Alcohol Withdrawal Syndrome: A Randomized Double-Blind Comparative Study versus Oxazepam. The GATE 1 Trial
|
Caputo, Fabio
|
|
2014
|
|
8 |
p. 743-752
|
artikel
|
| 86 |
Temporal Trends and Predictors of Drug Utilization and Outcomes in First-Ever Stroke Patients: A Population-Based Study Using the Singapore Stroke Registry
|
Yeo, See-Hwee
|
|
2019
|
|
8 |
p. 791-815
|
artikel
|
| 87 |
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
|
Biolato, Marco
|
|
|
|
8 |
p. 861-880
|
artikel
|
| 88 |
The Effect of Glatiramer Acetate on Retinal Nerve Fiber Layer Thickness in Patients with Relapsing–Remitting Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study
|
Zivadinov, Robert
|
|
2018
|
|
8 |
p. 763-770
|
artikel
|
| 89 |
The Impact of Newer Atypical Antipsychotics on Patient-Reported Outcomes in Schizophrenia
|
Awad, A. George
|
|
2013
|
|
8 |
p. 625-636
|
artikel
|
| 90 |
The Options for Neuraxial Drug Administration
|
Hermanns, Henning
|
|
|
|
8 |
p. 877-896
|
artikel
|
| 91 |
The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder
|
Gonçalves, Maria Carolina Bittencourt
|
|
|
|
8 |
p. 787-801
|
artikel
|
| 92 |
Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review
|
Willems, Laurent M.
|
|
|
|
8 |
p. 801-826
|
artikel
|
| 93 |
Therapeutic Potential of Baicalein in Alzheimer’s Disease and Parkinson’s Disease
|
Li, Yanwei
|
|
2017
|
|
8 |
p. 639-652
|
artikel
|
| 94 |
The Relationship between Benzodiazepine Use and Traffic Accidents
|
Smink, Beitske E.
|
|
2010
|
|
8 |
p. 639-653
|
artikel
|
| 95 |
The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics
|
Hert, Marc De
|
|
2015
|
|
8 |
p. 637-658
|
artikel
|
| 96 |
The Utilization of Low Dose Naltrexone for Chronic Pain
|
Poliwoda, Salomon
|
|
|
|
8 |
p. 663-670
|
artikel
|
| 97 |
Use of Emergency Medication in Adult Patients with Epilepsy: A Multicentre Cohort Study from Germany
|
Kadel, Jeannette
|
|
2018
|
|
8 |
p. 771-781
|
artikel
|
Tijdschrift beschrijving